An official website of the United States government
CDC HIV Evaluation
Program Performance Indicators
As specified in the President’s Management Agenda, CDC has incorporated program performance indicators into its cooperative agreements with HIV prevention providers. The purpose is to improve performance and accountability of programs. Beginning in 2005 all directly funded health departments and CBOs will report on measures of HIV prevention planning, service delivery, and evaluation activities. The performance indicators will be used to monitor progress in critical areas of HIV prevention. The specific components of HIV prevention programs addressed by the indicators include:
CDC Program Evaluation Projects and Resources
Transparent Reporting of Evaluations with Nonrandomized Designs (TREND)
Evaluation activities focus on results by:
- managing and measuring program performance
- improving the quality of HIV prevention programs
- promoting accountability
- HIV infections
- community planning
- prevention activities
- Counseling, testing, and referral services
- Partner counseling and referral services
- Prevention for HIV-infected persons
- Health education and risk-reduction activities
- Prevention of mother-to-child HIV transmission
- evaluation of reporting compliance
- capacity building activities
CDC Program Evaluation Projects and Resources
Community-Based Organizations
- Reduced Sexual Risk Behaviors Among People Living with HIV: Results from the Healthy Relationships Outcome Monitoring Project
- Evaluation of an HIV Prevention Intervention for African Americans and Hispanics: Findings from the VOICES/VOCES Community-Based Organization Behavioral Outcomes
Transparent Reporting of Evaluations with Nonrandomized Designs (TREND)
The Transparent Reporting of Evaluations with Nonrandomized Designs (TREND) Statement was developed in 2003, in consult with journal editors and HIV researchers, in an effort to improve the reporting standards for nonrandomized evaluations of behavioral and public health interventions. The key content on this TREND website is a 22-item checklist specifically developed to guide standardized reporting of nonrandomized controlled trials. This Checklist can be downloaded directly from the CDC website, along with a free pdf of the AJPH article that provides additional information about the TREND effort, process, and rationale for these reporting elements.
The TREND statement complements the widely adopted Consolidated Standards Of Reporting Trials (CONSORT) statement developed for randomized controlled trials. The TREND and CONSORT statements are important for researchers, journal editors, funding agencies, and reviewers as guides to improve the quality of reporting research evaluations in the peer-reviewed scientific literature. A collective effort in promoting transparent reporting is needed to improve research synthesis and advance evidence-based recommendations for best practices and policies. We encourage all researchers, funding agencies, journal editors, and reviewers to use the TREND Statement as a guide when designing evaluation studies and when reporting evaluation results.
- Transparent Reporting of Evaluations with Nonrandomized Designs (TREND)
- Consolidated Standards Of Reporting Trials (CONSORT)